Tumor Necrosis Factor (TNF)-lnduced Cutaneous Necrosis Is Mediated by TNF Receptor

Journal of Inflammation

Volumn 47, Issue 4, 1995, Pages 180-189

  Amar, Salomon ^a   Van Dyke, Thomas E ^a   Eugster, Hans Pietro ^a   Schultze, Nathalie ^a   Koebel, Pascale ^a   Bluethmann, Horst ^a  

^a BOSTON UNIVERSITY   (United States)

Author keywords

Gene knock out tumor necrosis factor tnf receptors skin necrosis lipopolysaccharide

Indexed keywords

LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; HISTOPATHOLOGY; MOUSE; MOUSE MUTANT; NONHUMAN; PRIORITY JOURNAL; SKIN INFLAMMATION; SKIN NECROSIS;

ANIMALS; ANTIGENS, CD; DERMATITIS, CONTACT; FEMALE; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NECROSIS; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; RECOMBINANT PROTEINS; SKIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0029432177     PISSN: 10787852     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Morrison DC, Ryan JL: Endotoxin and disease mechanisms. Annu Rev Med 38:417-432, 1987.
2. Marrack P, Kappler J: The staphylococcal enterotoxins and their relatives [published erratum appears in Science 248 (4959): 1066, see comments] Science 248:705-711, 1990.
3. Ryan J, Morrison DC: "Bactericidal Endotoxic Lipopolysaccharides. Vol. II: Immunopharmacology and Pathophysiology". Boca Raton FL: CRC Press, 1995.
4. Skeen MJ, Ziegler HK: Activation of gamma delta T cells for production of IFN-gamma is mediated by bacteria via macrophage-derived cytokines IL-1 and IL-12. J Immunol 154:5832-5841, 1995.
5. Nishimura H, Emoto M, Hiromatsu K, Yamamoto S, Matsuura K, Gomi H, Ikeda T, Itohara S, Yoshikai Y: The role of gamma delta T cells in priming macrophages to produce tumor necrosis factor-alpha. Eur J Immunol 25:1465-1468, 1995.
6. Skeen MJ, Miller MA, ShinnickTM, Ziegler HK: Regulation of murine macrophage IL-12 production. Activation of macrophages in vivo, restimulation in vitro, and modulation by other cytokines. J Immunol 156:1196-1206, 1996.
7. Cannon JG, Tompkins RG, Gelfand JA, Michie HR, Stanford GG, van der Meer JW, Endres S, Lonnemann G, Corsetti J, Chernow B, et al.: Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever. J Infect Dis 161:79-84, 1990.
8. Zheng H, Fletcher D, Kozak W, Jiang M, Hofmann KJ, Conn CA, Soszynski D, Grabiec C, Trumbauer ME, Shaw A: Resistance to fever induction and impaired acutephase response in interleukin-1 beta-deficient mice. Immunity 3:9-19, 1995.
9. Chai Z, Gatti S, Toniatti C, Poli V, Bartfai T: Interleukin (IL)-6 gene expression in the central nervous system is necessary for fever response to lipopolysaccharide or IL-1 beta: A study on IL-6-deficient mice. J Exp Med 183:311-316, 1996.
10. Gordon AH, Koj A: The acute phase response to injury and infection. In "The Acute-Phase Response to Injury and Infection." Gordon AH and Koj A (eds): Amsterdam: Elsevier, 139, 1985.
11. Dayer JM, Beutler B, Cerami A: Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts. J Exp Med 162:2163-2168, 1985.
12. Bone RC: The pathogenesis of sepsis. Ann Intern Med 115:457-469, 1991.
13. Parillo JE: Pathogenetic mechanisms of septic shock [see comments]. N Engl J Med 328:1471-1477, 1993.
14. Beutler B, Milsark IW, Cerami AC: Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 229:869-871, 1985.
15. Tracey KJ, Beutler B, Lowry SF, Merryweather J, Wolpe S, Milsark IW, Hairiri RJ, Fahey TJ, Zentella A, Albert JD, Shires GT, Cerami A: Shock and tissue injury induced by recombinant human cachectin. Science 234:470-474, 1986.
16. Miethke T, Wahl C, Heeg K, Echtenacher B, Krammer PH, Wagner H: T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: Critical role of tumor necrosis factor. J Exp Med 175:91-98, 1992.
17. Sharpe RJ, Margolis RJ, Askari M, Amento EP, Granstein RD: Induction of dermal and subcutaneous inflammation by recombinant cachectin/tumor necrosis factor (TNF alpha) in the mouse [published erratum appears in J Invest Dermatol 92(1):135, 1989]. J Invest Dermatol 91:353-357, 1988.
18. Piguet PF, Grau GE, Vassalli P: Subcutaneous perfusion of tumor necrosis factor induces local proliferation of fibroblasts, capillaries, and epidermal cells, or massive tissue necrosis. Am J Pathol 136:103-110, 1990.
19. Vandenabeele P, Declercq W, Beyaert R, Fiers W: Two tumour necrosis factor receptors: Structure and function. Trends Cell Biol 5:392-399, 1995.
20. Rothe J, Lesslauer W, Lotscher H, Lang Y, Koebel P, Kontgen F, Althage A, Zinkernagel R, Steinmetz M, Bluethmann H: Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 364:798-802, 1993b.
21. Erickson SL, de Sauvage FJ, Kikly K, Carver Moore K, Pitts Meek S, Gillett N, Sheehan KC, Schreiber RD, Goeddel DV, Moore MW: Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice. Int Immunol 372:560563, 1994.
22. Eugster HP, Muller M, Karrer U, Car BD, Schnyder B, Eng VM, Woerly G, Lehir M, Dipadova F, Aguet M, Zinkernagel R, Bluethmann H, Ryffel B: Multiple immune abnormalities in tumor necrosis factor and lymphotoxin-alpha double-deficient mice. Int Immunol 8:23-36, 1996.
23. Morrison DC, Leive L Fractions of lipopolysaccharide from Escherichia coli 0111:B4 prepared by two extraction procedures. J Biol Chem 250:2911-2919, 1975.
24. Shapira L, Takashiba S, Champagne C, Amar S, Van Dyke TE: Involvement of protein kinase C and protein tyrosine kinase in lipopolysaccharide-induced TNF-alpha and IL-1 beta production by human monocytes. J Immunol 153:1818-1824, 1994.
25. Dembic Z, Loetscher H, Gubler U, Pan YCE, Lahm HW, Gentz R, Brockhaus M, Lesslauer W: Two human TNF receptors have similar extracellular domain sequences. Cytokine 2:231-237, 1990.
26. Smith CA, Farrah T, Goodwin RG: The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death. Cell 76:959-962, 1994.
27. Bazzoni F, Beutler B: Comparitve expression of TNFalpha alleles from normal and autoimmune-prone MHC haplotypes. J Inflamm 45:106-114, 1995.
28. Vandenabeele P, Declercq W, Vercammen D, Van de Craen M, Grooten J, Loetscher H, Brockhaus M, Lesslauer W, Fiers W: Functional characterization of the human tumor necrosis factor receptor p75 in a transfected rat/mouse T cell hybridoma. J Exp Med 176:1015-1024, 1992.
29. Tartaglia LA, Weber RF, Figari IS, Reynolds C, Palladino MAJ, Goeddel DV: The two different receptors for tumor necrosis factor mediate distinct cellular responsed. Proc Natl Acad Sci USA 88:9292-9296, 1991.
30. Tartaglia LA, Goeddel DV, Reynolds C, Figari IS, Weber RF, Fendly BM, Palladino MJ: Stimulation of human T-cell proliferation by specific activation of the 75-kDa tumor necrosis factor receptor. J Immunol 151:4637-4641, 1993a.
31. Tartaglia LA, Pennica D, Goeddel DV: Ligand passing: The 75-kDa tumor nicrosis factor (TNF) receptor recruits TI\IF for signaling by the 55-kDa TNF receptor. J Biol Chem 268:18542-18548, 1993b.
32. Tartaglia LA, Goeddel DV: Two TNF receptors. Immunol Today 13:151-153, 1992.
33. Hohmann HP, Brockhaus M, Baeuerle P, Remy R, Kolbeck R, van Loon A: Expression of the types A and B tumor necrosis factor (TNF) receptors is independently regulated, and both receptors mediate activation of the transcription factor NF-KB. J Biol Chem 265:2240922417, 1990.
34. Gehr G, Gentz R, Brockhaus M, Loetscher H, Lesslauer W: Both tumor necrosis factor teceptor types mediate proliferative signals in human mononuclear cell activation. J Immunol 149:911-917, 1992.
35. Heller RA, Song K, Fan N, Chang DJ: The p70 tumor nicrosis factor receptor mediates cytotoxicity. Cell 70:47-56, 1992.
36. Laegreid A, Medvedev A, Nonstad U, Bombara MP, Ranges G, Sundan A, Espevik T: Tumor necrosis factor receptor p75 mediates cell-specific activation of nuclear factor dappa B and induction of human cytomegalovirus enhancer. J Biol Chem 269:7785-7791, 1994.
37. Heller RA, Kranke M: Tumor necrosis factor receptormediated signaling pathways. J Cell Biol 126:5-9,1994.
38. Rothe J, Bluethmann H, Gentz R, Lesslauer W, Steinmetz M: Genomic organization and promoter function of the murine tumor necrosis factor teceptor beta gene. Mol Immunol 30:165-175, 1993a.
39. Grell M, Douni E, Wajant H, Lohden M, Clauss M, Maxeiner B, Georgopoulos S, Lesslauer W, Kollias G, Pfizenmaier K, et al.: The transmembrane form of tumor nicrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 83:793-802, 1995.
40. Sheehan KC, Pinckard JK, Arthur CD, Dehner LP, Goeddel DV, Schreiber RD: Monoclonal antibodies specific for murine p55 and p75 tumor necrosis factor receptors: Identification of a novel in vivo role for p75. J Exp Med 181:607-617, 1995.
41. Dinarello CA: Biology of interleukin 1. Faseb J 2:108-115, 1988.